Alpha DNA Investment Management’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-20,440
Closed -$427K 231
2024
Q2
$427K Buy
+20,440
New +$427K 0.17% 142